Sarcopenia represents an independent adverse event in metastatic castration-resistant prostate cancer (mCRPC) patients candidates to Radium-223 therapy
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要